Evommune (EVMN) EPS (Basic) (2024 - 2026)
Evommune (EVMN) posted quarterly EPS (Basic) of -$3.38 for Q1 2026, up 64.56% year-over-year from -$2.05 in Q1 2025, and up 26.63% quarter-over-quarter from -$4.6 in Q4 2025.
Evommune (EVMN) EPS (Basic) (2024 - 2026) Analysis & Trends
Evommune (EVMN) has reported EPS (Basic) for 3 consecutive years, with -$3.38 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 64.56% year-over-year to -$3.38; the TTM figure through Mar 2026 stood at -$5.02 (changed N/A YoY), while the FY2025 annual figure was -$21.55, up 51.89% from the prior year.
- EPS (Basic) improved to -$3.38 in Q1 2026 per EVMN's latest filing, from -$4.6 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$3.38 in Q1 2026 and bottomed at -$13.75 in Q4 2024.
- Historically, EPS (Basic) has averaged -$8.3 across 3 years, with a median of -$8.8 in 2025.
- On a YoY basis, EPS (Basic) climbed as much as 66.53% in 2025 and fell as far as 22.85% in 2025.
- Evommune's EPS (Basic) stood at -$13.75 in 2024, then surged by 66.53% to -$4.6 in 2025, then increased by 26.63% to -$3.38 in 2026.
- Business Quant data shows EVMN's EPS (Basic) at -$3.38 in Q1 2026, -$4.6 in Q4 2025, and -$8.07 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Evommune | 531.53 Mn | 330.73 Mn | - | -1.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.87 |
| Mar 31, 2026 | -3.38 |
| Dec 31, 2025 | -4.60 |
| Sep 30, 2025 | -8.07 |
| Mar 31, 2025 | -9.52 |
| Dec 31, 2024 | -13.75 |
| Sep 30, 2024 | -10.47 |